Watchlist Price Alert

Galmed Pharmaceuticals Lt... (GLMD)

NASDAQ: GLMD · Real-Time Price · USD

1.29

0.01 (0.78%)

At close: May 13, 2025, 3:59 PM

1.29

0.00%

Pre-market: May 14, 2025, 04:00 AM EDT

Galmed Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-7.52M	-6.91M	-17.87M	-32.47M	-28.77M	-20.46M	-9.86M	-12.3M	-16.95M
Depreciation & Amortization	83K	31K	35K	42K	39K	35K	387K	239K	169K
Stock-Based Compensation	531K	892K	1.3M	1.89M	2.07M	2.23M	1.78M	1.39M	1.63M
Other Working Capital	35K	468K	-140K	-275K	54K	-750K	-538K	-1.35M	1.71M
Other Non-Cash Items	1.75M	-280K	485K	13K	-285K	-63K	-144K	-167K	1.67M
Deferred Income Tax	n/a	n/a	n/a	84K	-437K	-114K	12K	164K	-1.4M
Change in Working Capital	-728K	132K	-2.45M	-2.45M	1.1M	3.44M	-1.21M	-1.4M	2.75M
Operating Cash Flow	-5.88M	-6.14M	-18.5M	-32.89M	-26.29M	-14.94M	-9.02M	-12.07M	-12.13M
Capital Expenditures	n/a	n/a	-4K	-11K	-44K	-12K	-90K	-21K	-17K
Cash Acquisitions	n/a	-1.5M	-17.57K	n/a	-24.94M	21.8M	6.08M	n/a	13K
Purchase of Investments	-6.37M	-6.33M	-3.87M	-13.57M	-55.03M	-94.41M	-98.35M	-3.87M	-7.62M
Sales Maturities Of Investments	5.5M	8.63M	21.44M	25.04M	71.61M	101.1M	38.42M	10.32M	13.96M
Other Investing Acitivies	-250K	n/a	17.57K	-1K	24.94M	-21.8M	-6.08M	9K	13K
Investing Cash Flow	-1.11M	800K	17.56M	11.46M	16.54M	6.68M	-60.02M	6.44M	6.34M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a	n/a	61K	143K	1.03M	530K	255K
Financial Cash Flow	8.79M	6.18M	70K	17.37M	768K	143K	80.18M	15.55M	4.73M
Net Cash Flow	1.79M	848K	-868K	-4.06M	-8.98M	-8.12M	11.14M	9.92M	-1.06M
Free Cash Flow	-5.88M	-6.14M	-18.5M	-32.9M	-26.33M	-14.95M	-9.11M	-12.09M	-12.15M